LAG3 and neoplasm: LAG3.NC-CD4Cre and LAG3.NC-ThPOKCreERT2 mice resist anti-PD1 therapy and succumb to MC38 tumor growth, compared to ~40% of controls and LAG3.NC-E8ICre.GFP mice becoming tumor-free.